Positive Final Data from HyCAMP Phase II Trial in Metastatic
BRISBANE, Australia, May 29, 2007 /PRNewswire/ -- Phase II
results exceed expectations - Alchemia prepares for FDA talks on
Australian drug development company Alchemia Limited will
commence discussions with the US Food and Drug Administration (FDA)
following the successful conclusion...